Tangen Biosciences

Tangen Biosciences was founded in 2013 and is headquartered in Connecticut, USA. It is a medical device company focusing on the development of rapid nucleic acid testing. Tangen Biosciences is led by CEO Richard C. Birkmeyer, an experienced executive who joined the company in November 2018.The TangenDx™ system developed by Tangen Biosciences enables rapid isothermal nucleic acid testing with the specificity and sensitivity of polymerase chain reaction (PCR) amplification. The design of the TangenDx™ system allows for remote site testing using battery power in an easy-to-use format.